<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>EXCLUSIVE: US FDA shelves commissioner's voucher program for speedy drug reviews, sources say — Live Feed</title><link>https://www.live-feeds.com/feed/exclusive-us-fda-shelves-commissioner-s-voucher-program-for-speedy-drug-reviews-sources-say</link><atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.live-feeds.com/feed/exclusive-us-fda-shelves-commissioner-s-voucher-program-for-speedy-drug-reviews-sources-say/rss.xml" rel="self" type="application/rss+xml"/><description>Continuously updated, source-cited coverage.</description>
<item><title>FDA Shelves Commissioner's Voucher Program for Speedy Drug Reviews</title><link>https://www.live-feeds.com/feed/exclusive-us-fda-shelves-commissioner-s-voucher-program-for-speedy-drug-reviews-sources-say</link><guid isPermaLink="false">https://www.live-feeds.com/feed/exclusive-us-fda-shelves-commissioner-s-voucher-program-for-speedy-drug-reviews-sources-say#u204097</guid><pubDate>Mon, 16 Nov 2026 14:30:45 +0000</pubDate><description>The US Food and Drug Administration has shelved the fast-track drug review initiative launched during the Trump administration by former Commissioner Marty Makary. Sources indicate the controversial speedy review program is now dead. The move comes amid reports of agency chaos and arrives ahead of a Senate vote on Overton. The halted program previously allowed for priority review vouchers, generating significant industry discussion and debate before its apparent termination.Why it mattersThe initiative served as a flagship drug fast-track program under former Commissioner Marty Makary during t</description></item>
</channel></rss>